Related Experiment Video
Updated: May 20, 2026

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus
Published on: June 23, 2022
Prevalence of seizures in children infected with human immunodeficiency virus
Pauline Samia1, Reneva Petersen, Kathleen G Walker
1Department of Paediatric Neurology, Red Cross Children's Hospital, University of Cape Town, South Africa.
Insights
Pediatric seizures affect nearly 8% of children with human immunodeficiency virus (HIV). These children often experience more neurological deficits and developmental delays, highlighting the need for careful management.
Area of Science:
- Pediatric Neurology
- Infectious Diseases
- Clinical Pharmacology
Background:
- Human immunodeficiency virus (HIV) infection can present with neurological complications in children.
- Seizures are a significant neurological manifestation in pediatric HIV cases.
Purpose of the Study:
- To investigate the prevalence and characteristics of seizures in children with HIV.
- To examine the association between seizures and other neurological/developmental outcomes in this population.
- To assess antiepileptic drug (AED) management and outcomes.
Main Methods:
- Retrospective analysis of 354 pediatric HIV patients.
- Identification of a subgroup experiencing seizures.
- Comparison of neurological deficits and developmental delay between seizure and non-seizure groups.
- Review of AED treatments and drug levels.
Main Results:
- Seizures occurred in 7.6% of pediatric HIV patients.
- Patients with seizures had significantly higher rates of neurological deficits and developmental delay (P < .001).
- Common AEDs included sodium valproate, phenobarbital, and diazepam; 5 children required combination therapy. Suboptimal valproic acid levels were noted in 3 patients.
Conclusions:
- Seizures are a notable complication in pediatric HIV, associated with poorer neurological and developmental outcomes.
- Optimal seizure management in HIV-infected children may benefit from AED level monitoring, especially when co-administered with antiretroviral therapy.
- Further research into the neuro-mechanisms and optimal treatment strategies for seizures in pediatric HIV is warranted.
Abstract:
A retrospective study of 354 human immunodeficiency virus (HIV)-infected patients identified a subgroup of 27 children with seizures (7.6%, 95% confidence interval: 5.1%-10.9%). Of the total group, 13% (n = 46) had identifiable neurologic deficits and 30% (n = 107) had developmental delay. Both observations were significantly more frequent in the subgroup of patients with seizures (P < .001). The median age of patients with seizures was 20 months (range, 8-87 months) and the median baseline CD4 percentage was 13.5% (interquartile range, 8%-23%). Seizures were treated with sodium valproate (n = 11), phenobarbital (n = 3), diazepam (n = 2), lamotrigine (n = 1), and carbamazepine (n = 1). Combination therapy was required for 5 children. Suboptimal valproic acid levels were recorded for 3 patients. When resources are available, antiepileptic drug level monitoring is advised for children who require both antiepileptic and antiretroviral medications to facilitate optimal seizure management.
More Related Videos
13:58Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
Published on: September 26, 2011
05:51Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Related Concept Videos
Encephalitis l: Introduction
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Cytomegalovirus Disease